Micro-/Nano-scale Tools for Biomarker Discovery and Electronic Point-of-Care Diagnostics for Infectious Diseases

Abstract

The current COVID-19 pandemic and other recent outbreaks such as Ebola, MERS, SARS, and H1N1 have underscored the need for early detection and continued surveillance of emerging and re-emerging infectious diseases. The heterogeneity of disease in COVID-19 – a large number of mild or asymptomatic cases coupled with the relatively rapid degradation in symptoms in some patients – poses a unique challenge for the healthcare system and emphasizes the need for developing predictive biomarkers of disease severity. We are harnessing microscale and nanoscale technology to solve these challenges by developing devices for high-throughput discovery and inexpensive electronic detection of diagnostic & prognostic biomarkers. Here, I will present our progress with these approaches in the context of COVID-19 and beyond.